Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

• Status: Completed
• Trial end date: 2006-10-01

Summary

The purpose of this study is to determine the effect of pioglitazone, once daily (QD), and atorvastatin combination therapy compared to atorvastatin monotherapy in patients at risk for cardiovascular disease.

• Phase: Phase 2

Details

• Lead Sponsor: Takeda
• Treatments: Atorvastatin; Atorvastatin Calcium; Pioglitazone